finance
Business planning is at risk...
Many of the fundamentals for pharmaceutical planning are in flux, so financial planning and analytics must adapt. Patent expiration, unavailable prescriber behavior, reliability of syndicated demand data, downstream price speculation and other factors are rapidly altering the pillars of solid financial analysis for most major pharmaceutical manufacturers.
Channel & pipeline transparency is key
Visibility into retail, mail order, and LTC inventories have always posed challenges; however, in today’s environment of strained economic environment and flat or declining growth models, having a reliable metrics is more critical than ever.
IntegriChain’s data enrichment and analytic services provide manufacturers with a high-resolution view into every facet of the distribution chain. Retail DC and in-store pharmacy inventory measures, in-transit calculations and wholesaler inventory levels can now be leveraged for long-term forecasting, short-term monitoring, and sales reporting.
IntegriChain benefits to financial executives include:
- Improved Business Planning and Net Sales Predictability
- Improve accrual accuracy
- Gain clarity to true demand and sales growth
- Ensure accurate capture of TRx growth & inventory movement
- Improve downstream order & inventory monitoring
- Communicate to investors with confidence and clarity
- Improve brand resource allocations
Improved Forecast Credibility & Alignment with Sales Reporting
Maximizing the Value of Price Increases
Optimizing Net Sales Visibility & Financial Performance
Optimize your financial performance by connecting actual sales to true demand.
Are your auditors asking you about channel activity?
In the past, many pharmaceutical companies have tried to use EDI852 and EDI867 to get better insight into revenue recognition; however, they have been frustrated by the lack of fidelity and completeness of the information. IntegriChain’s Enriched Channel Sales™ provides a high-fidelity, complete and accurate view of the entire channel thus allowing finance to leverage channel data as the auditors are requesting.
Achieve additional business intelligence with high-powered guided analytics that deliver greater insight into manufacturers' direct data assets.
Gain visibility to all channels, all chains and institutional networks with the industry's only 100%, pharmacy identified sell-in data set built from actual sales data.
Get a high-resolution picture of long-term demand forecasting, short-term wholesale and retail inventories, and accurate total pipeline metrics.
Ensure contract compliance and identify missing reverse- or duplicate-chargebacks. Validate 852 & 867 values for accurate inventory roll-forward calculations.